Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0975 USD | -2.24% | -8.88% | -32.94% |
Jun. 07 | Galera Therapeutics, Inc. Eliminates Robert A. Beardsley as Chief Operating Officer | CI |
Jun. 06 | Galera Therapeutics, Inc.(OTCPK:GRTX) dropped from S&P TMI Index | CI |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 7.91M |
---|---|---|---|---|---|
Net income 2022 | -62M | Net income 2023 | -59M | EV / Sales 2022 | - |
Net Debt 2022 | 108M | Net Debt 2023 | 134M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.65
x | P/E ratio 2023 |
-0.11
x | Employees | 7 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 63.85% |
1 day | +1.01% | ||
1 week | -16.85% | ||
Current month | -53.65% | ||
1 month | -43.38% | ||
3 months | -54.70% | ||
6 months | -20.87% | ||
Current year | -31.43% |
Managers | Title | Age | Since |
---|---|---|---|
J. Sorensen
CEO | Chief Executive Officer | 67 | 12-10-31 |
Dennis P. Riley
FOU | Founder | - | 08-12-31 |
Chris Degnan
DFI | Director of Finance/CFO | 44 | 19-10-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Powell
CHM | Chairman | 69 | 16-11-27 |
Kevin Lokay
BRD | Director/Board Member | 67 | 19-02-28 |
J. Sorensen
CEO | Chief Executive Officer | 67 | 12-10-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-12 | 0.0975 | -2.24% | 152 761 |
24-06-11 | 0.0997 | +1.01% | 471,302 |
24-06-10 | 0.0987 | -9.45% | 988,906 |
24-06-07 | 0.109 | -3.11% | 520,069 |
24-06-06 | 0.1125 | +5.14% | 1,894,417 |
Delayed Quote OTC Markets, June 11, 2024 at 03:55 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-31.43% | 5.42M | |
+18.34% | 124B | |
+15.06% | 109B | |
-6.39% | 23.84B | |
+0.96% | 22.42B | |
-15.29% | 17.5B | |
-41.64% | 16.43B | |
-12.07% | 16.61B | |
+1.05% | 13.4B | |
+25.87% | 11.47B |
- Stock Market
- Equities
- GRTX Stock